Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1,4-Butanediol SCHEMBL17186662 | 0.89 | SMN1; SMN2 (0.35) | ALDH1A1 | |
| SCHEMBL14775309 | 0.87 | — | — | |
| SCHEMBL14118335 | 0.81 | — | — | |
| SCHEMBL2155449 | 0.81 | — | — | |
| SCHEMBL14118332 | 0.81 | — | — | |
| SCHEMBL28210364 | 0.79 | — | — | |
| SCHEMBL10360193 | 0.79 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL4189242 | 0.79 | — | — | |
| SCHEMBL18741028 | 0.79 | TSHR (0.38) | ALDH1A1 | |
| SCHEMBL3896689 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12255288-B2 | Nonaqueous electrolytic solution for battery and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2025-03-18 | — | — | US | disclosed |
| CN-113646931-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2024-09-10 | — | — | CN | disclosed |
| WO-2022104710-A1 | CYCLIC SULFONATE LITHIUM-ION BATTERY ELECTROLYTE SOLUTION ADDITIVE, PREPARATION METHOD FOR SAME, AND APPLICATIONS THEREOF | 中节能万润股份有限公司 | 2022-05-27 | — | — | WO | disclosed |
| US-20220158247-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2022-05-19 | — | — | US | disclosed |
| EP-3951950-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES, AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-3211706-A1 | LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2017-08-30 | — | — | EP | disclosed |
| EP-2571090-B9 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-9553333-B2 | Nonaqueous electrolytic solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-01-24 | — | — | US | disclosed |
| EP-2571090-B1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2016-09-07 | — | — | EP | disclosed |
| EP-2618418-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20130071731-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| US-20130071730-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2571089-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-2571090-A1 | NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1572615-A1 | PROCESS FOR THE SYNTHESIS OF PEPTIDES CONTAINING A 4-HYDORXY-PROLINE SUBSTRUCTURE | Novartis AG (CH) | 2005-09-14 | — | — | EP | disclosed |
| EP-1089988-A4 | FLUOROPHENYL RESIN COMPOUNDS | AVENTIS PHARM PROD INC (US) | 2005-01-19 | — | — | EP | disclosed |
| WO-2004052817-A1 | PROCESS FOR PEPTIDE SYNTHESIS OF PEPTIDES CONTAINING A 4-HYDROXY-PROLINE SUBSTRUCTURE | NOVARTIS AG (CH) | 2004-06-24 | — | — | WO | disclosed |
| EP-1089988-A1 | FLUOROPHENYL RESIN COMPOUNDS | Aventis Pharmaceuticals Products Inc. (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067228-A1 | FLUOROPHENYL RESIN COMPOUNDS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | SLC9B2, SCN11A, NUCB2 | ALDH1A1 3428/4885SOAT1 2688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.